Work

Safety and PK results from a phase Ib study of AL3818 (anlotinib) hydrochloride in subjects with ovarian, cervical, and endometrial cancers.

Year: 2017

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2017.35.15_suppl.e17071

Authors: Theresa Louise Werner, Esther Kannapel, Judy Chen, Melissa Chen, Adam Louis Cohen

Institutions: University of Utah, Huntsman Cancer Institute, Advenchen Laboratories, LLC (United States)

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2773039266

Cites:

Cited by: 8

Related to: 10